Skip to main content

Adenomyosis

1
Pipeline Programs
4
Companies
5
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

4 companies ranked by most advanced pipeline stage

ViiV Healthcare
ViiV HealthcareNC - Durham
1 program
1
EpelsibanPhase 2
UNION therapeutics
UNION therapeuticsDenmark - Hellerup
3 programs
A multi-omics analysisN/A1 trial
Placement of levonorgestrel-releasing intrauterine systemN/A1 trial
whole exome sequencing and RNA-sequencingN/A1 trial
Active Trials
NCT03742843Unknown200Est. Nov 2020
NCT03027648Completed1,100Est. Jan 2017
NCT04010487Unknown40Est. Aug 2021
Hologic
HologicMARLBOROUGH, MA
1 program
RF TreatmentN/A1 trial
Active Trials
NCT05130190Completed15Est. Jan 2025
Gedeon Richter
Gedeon RichterHungary - Budapest
1 program
Ulipristal acetatePHASE_21 trial
Active Trials
NCT02587000Completed26Est. Mar 2020

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Gedeon RichterUlipristal acetate
HologicRF Treatment
UNION therapeuticswhole exome sequencing and RNA-sequencing
UNION therapeuticsA multi-omics analysis
UNION therapeuticsPlacement of levonorgestrel-releasing intrauterine system

Clinical Trials (5)

Total enrollment: 1,381 patients across 5 trials

NCT02587000Gedeon RichterUlipristal acetate

Adenomyosis and Ulipristal Acetate

Start: Jun 2015Est. completion: Mar 202026 patients
Phase 2Completed
NCT05130190HologicRF Treatment

Radiofrequency Ablation of Adenomyosis

Start: Jul 2022Est. completion: Jan 202515 patients
N/ACompleted
NCT04010487UNION therapeuticswhole exome sequencing and RNA-sequencing

Multi-omics Study on the Pathogenesis of Malignant Transformation of Adenomyosis

Start: Jul 2019Est. completion: Aug 202140 patients
N/AUnknown
NCT03742843UNION therapeuticsA multi-omics analysis

A Multi-omics Study of Adenomyosis

Start: Nov 2018Est. completion: Nov 2020200 patients
N/AUnknown
NCT03027648UNION therapeuticsPlacement of levonorgestrel-releasing intrauterine system

Levonorgestrel-releasing Intrauterine System for the Treatment of Symptomatic Adenomyosis

Start: Dec 2006Est. completion: Jan 20171,100 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

4 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.